Rovaris, Marco
 Distribuzione geografica
Continente #
NA - Nord America 186
EU - Europa 91
AS - Asia 54
AF - Africa 2
OC - Oceania 1
Totale 334
Nazione #
US - Stati Uniti d'America 183
IT - Italia 46
SG - Singapore 30
IN - India 13
IE - Irlanda 12
SE - Svezia 8
BG - Bulgaria 7
ID - Indonesia 6
FI - Finlandia 4
TW - Taiwan 4
CA - Canada 3
DE - Germania 3
GB - Regno Unito 2
RO - Romania 2
TG - Togo 2
UA - Ucraina 2
AU - Australia 1
CH - Svizzera 1
CN - Cina 1
ES - Italia 1
NL - Olanda 1
PL - Polonia 1
RU - Federazione Russa 1
Totale 334
Città #
Fairfield 28
Singapore 22
Cambridge 14
Chandler 13
Dublin 12
San Paolo di Civitate 12
Santa Clara 12
Rome 11
Wilmington 11
Houston 10
Ashburn 9
Woodbridge 8
Sofia 7
Ann Arbor 6
Jakarta 6
Lawrence 6
Princeton 6
Boston 5
Seattle 5
Helsinki 4
San Diego 4
Taipei 4
Fasano 3
Naples 3
Stockholm 3
Toronto 3
Andover 2
Lomé 2
New York 2
Nuremberg 2
Vicenza 2
Alba 1
Bacoli 1
Beijing 1
Boardman 1
Duncan 1
Essendon 1
Ferrara 1
Manchester 1
Mannheim 1
Millbury 1
Moscow 1
Norwalk 1
Pamplona 1
Pesaro 1
Pomezia 1
Prescot 1
Redwood City 1
Warsaw 1
Zurich 1
Totale 256
Nome #
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors 61
Italian consensus on treatment of spasticity in multiple sclerosis 59
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies 51
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 47
The Italian multiple sclerosis register 45
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 41
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 23
Evaluation of drivers of treatment switch in relapsing multiple sclerosis. A study from the Italian MS Registry 21
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study 18
COVID-19 severity in multiple sclerosis 4
null 3
Totale 373
Categoria #
all - tutte 1.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 48 3 1 4 2 8
2021/202293 11 7 5 3 18 15 0 6 7 4 10 7
2022/202371 13 20 2 3 11 3 1 6 6 1 1 4
2023/202465 1 6 1 5 4 11 5 5 4 13 6 4
2024/202578 4 4 10 16 19 24 1 0 0 0 0 0
Totale 373